Roles of microRNAs in renal disorders related to primary podocyte dysfunction

R Iranzad, R Motavalli, A Ghassabi, R Pourakbari… - Life Sciences, 2021 - Elsevier
Through the regulation of gene expression, microRNAs (miRNAs) are capable of modulating
vital biological processes, such as proliferation, differentiation, and apoptosis. Several …

The management of membranous nephropathy—an update

F Caravaca-Fontán… - Nephrology Dialysis …, 2022 - academic.oup.com
In recent decades, several important advances have taken place in the understanding of the
pathogenesis underlying membranous nephropathy (MN) that have sparked renewed …

Ten tips on immunosuppression in primary membranous nephropathy

H Trujillo, F Caravaca-Fontán… - Clinical Kidney Journal, 2024 - academic.oup.com
Membranous nephropathy (MN) management poses challenges, particularly in selecting
appropriate immunosuppressive treatments (IST) and monitoring disease progression and …

Identification of hub genes and immune-related pathways for membranous nephropathy by bioinformatics analysis

XY Cai, ZF Wang, SW Ge, G Xu - Frontiers in Physiology, 2022 - frontiersin.org
OBJECTIVE: We aim to explore the detailed molecular mechanisms of membrane
nephropathy (MN) related genes by bioinformatics analysis. METHODS: Two microarray …

The association between serum complement 4 and kidney disease progression in idiopathic membranous nephropathy: a multicenter retrospective cohort study

J Liu, Y Zha, P Zhang, P He, L He - Frontiers in Immunology, 2022 - frontiersin.org
Introduction Complement system plays an important role in the pathogenesis of idiopathic
membranous nephropathy (IMN), however, the relationship between serum complement 4 …

Rituximab in patients with membranous nephropathy and kidney insufficiency

Y Guo, L Wang, Y Wang, X Li, Z Zhai, L Yu… - Frontiers in …, 2022 - frontiersin.org
Introduction: Patients with membranous nephropathy and kidney insufficiency have an
extremely high risk of progression to end-stage renal disease. Whether rituximab can …

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with …

Y Guo, N Guo, J Wang, R Wang, L Tang - Renal Failure, 2021 - Taylor & Francis
Introduction Primary membranous nephropathy (PMN) is one common cause of end-stage
kidney disease. There is no optimal treatment for PMN patients with sub-nephrotic …

Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression

A Trautmann, S Seide, BS Lipska-Ziętkiewicz… - Pediatric …, 2023 - Springer
Background The aim of the current PodoNet registry analysis was to evaluate the outcome of
steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with …

Membranous nephropathy associated with indigenous Indian medications containing heavy metals

MN Kumar, PS Priyamvada, A Chellappan… - Kidney International …, 2020 - kireports.org
Results During the 2014–2019 period, a total number of 143 cases were diagnosed with
MN. Serum and urine Mercury levels were measured in 11 patients with a history of …

Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren's syndrome: a 6-year retrospective study

L Guo, S Zhao, X Liu - Frontiers in Immunology, 2024 - frontiersin.org
Objectives Nephritis is a life-threatening complication of primary Sjögren's syndrome (pSS),
with membranous nephropathy (MN) being prevalent. Renal biopsy is the gold standard for …